|

rhTSH Clinical Trials

1 actively recruiting trial across 1 location

Also known as: thyrotropin alfa

Pipeline

Phase 2: 1

Top Sponsors

  • Massachusetts General Hospital1

Indications

  • Unresectable Thyroid Gland Carcinoma1
  • Metastatic Thyroid Cancer1
  • Papillary Thyroid Cancer1
  • Follicular Thyroid Cancer1
  • Thyroid Carcinoma1

Washington D.C., District of Columbia1 trial

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

MedStar Washington Hospital Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.